Latest filing published 15 Feb 2018 for Foundation Medicine, Inc., €1.5M.
Filing timeline
BuySaleInsider track record
Steven J. Kafka: trading record in brief
Steven J. Kafka appears in our data through filings on Foundation Medicine, Inc. shares, published by SEC (Form 4). In total, 88 filings cover trades dated from 9 April 2014 to 13 February 2018.
The open-market record consists of 58 sales worth €13.8M, with no purchase. Besides market trades, the filings include 5 share grants and 23 option exercises. In 2018 alone, the filings show no purchases and 5 sales.
The latest filing, published on 15 February 2018, reports an open-market sale of €1.5M in Foundation Medicine, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Steven J. Kafka
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 29,791 shares@ US$61.5511.1% of flowCommon StockSEC:0001209191-18-010349:0
- 23,064 shares@ US$70.139.7% of flowCommon StockSEC:0001209191-18-008786:0
- 4,148 shares@ US$65.711.7% of flowCommon StockSEC:0001209191-18-004228:0
- 157 shares@ US$64.000.1% of flowCommon StockSEC:0001209191-18-001130:0
- 2,257 shares@ US$64.000.9% of flowCommon StockSEC:0001209191-18-001130:1
- 1,562 shares@ US$4.160.0% of flowCommon StockSEC:0001209191-17-064983:0
- 1,562 shares@ US$61.660.6% of flowCommon StockSEC:0001209191-17-064983:1
- 35,156 shares@ US$7.121.6% of flowCommon StockSEC:0001209191-17-064983:2
- 35,156 shares@ US$61.6613.7% of flowCommon StockSEC:0001209191-17-064983:3
- 747 shares@ US$4.160.0% of flowCommon StockSEC:0001209191-17-064983:4
- 747 shares@ US$61.660.3% of flowCommon StockSEC:0001209191-17-064983:5
- 50,896 shares@ US$4.161.3% of flowCommon StockSEC:0001209191-17-064983:6
- 50,896 shares@ US$61.6619.8% of flowCommon StockSEC:0001209191-17-064983:7
- 5,774 shares@ US$4.160.2% of flowCommon StockSEC:0001209191-17-064390:0
- 5,774 shares@ US$58.572.1% of flowCommon StockSEC:0001209191-17-064390:1
- 3,361 shares@ US$44.620.9% of flowCommon StockSEC:0001209191-17-057009:0
- 153 shares@ US$38.800.0% of flowCommon StockSEC:0001209191-17-055739:0
- 3,048 shares@ US$38.800.8% of flowCommon StockSEC:0001209191-17-055739:1
- 11,781 shares@ US$39.153.0% of flowCommon StockSEC:0001209191-17-045329:0
- 12,310 shares@ US$38.983.2% of flowCommon StockSEC:0001209191-17-044356:0
- 104 shares@ US$38.840.0% of flowCommon StockSEC:0001209191-17-044356:1
- 4,284 shares@ US$38.841.1% of flowCommon StockSEC:0001209191-17-044356:2
- 3,010 shares@ US$38.840.8% of flowCommon StockSEC:0001209191-17-044356:3
- 4,405 shares@ US$34.551.1% of flowCommon StockSEC:0001209191-17-027676:0
- 103 shares@ US$31.960.0% of flowCommon StockSEC:0001209191-17-025576:0
25 of 87 declarations
